Pulse contour analysis calibrated by Trans-pulmonar thermodilution (Picco Plus®) for the perioperative management of a caesarean section in a patient with severe cardiomyopathy  by Brogly, Nicolas et al.
Rev Bras Anestesiol. 2016;66(3):329--332
REVISTA
BRASILEIRA  DE
ANESTESIOLOGIA Publicação  Oﬁcial  da  Sociedade  Brasileira  de  Anestesiologiawww.sba.com.br
CLINICAL INFORMATION
Pulse  contour  analysis  calibrated  by  Trans-pulmonar
thermodilution (Picco  Plus®) for  the  perioperative  management  of
a caesarean  section  in a  patient  with severe  cardiomyopathy
Nicolas Brogly, Renato Schiraldi, Laura Puertas, Genaro Maggi ∗,
Eduardo Alonso Yanci, Ever Hugo Martinez Maldonado, Emilia Guasch Arévalo,
Fernando  Gilsanz Rodríguez
Sociedad  Espan˜ola  Anestesiologia,  Reanimacion  y  Terapeutica  del  Dolor,  Madrid,  Spain
Received 28  June  2013;  accepted  9  September  2013
Available  online  29  October  2013
KEYWORDS
Caesarean  section;
Cardiac  monitoring;
Myocardiopathy
Abstract
Background:  The  delivery  of  cardiac  patients  is  a  challenge  for  the  anaesthesiologist,  to  whom
the welfare  of  both  the  mother  and  the  foetus  is  a  main  issue.  In  case  of  caesarean  section,
advanced  monitoring  allows  to  optimize  haemodynamic  condition  and  to  improve  morbidity  and
mortality.
Objective:  To  describe  the  use  of  pulse  contour  analysis  calibrated  by  Trans-pulmonar  thermod-
ilution (Picco  Plus®)  for  the  perioperative  management  of  a  caesarean  section  in  a  patient  with
severe cardiomyopathy.
Case  report:  We  describe  the  case  of  a  28-year-old  woman  with  a  congenital  heart  disease  who
was submitted  to  a  caesarean  section  under  general  anaesthesia  for  maternal  pathology  and
foetal breech  presentation.  Intra-  and  post-operative  management  was  optimized  by  advanced
haemodynamic  monitorization  obtained  by  pulse  contour  wave  analysis  and  thermodilution  cal-
ibration  (Picco  Plus® monitor).  The  information  about  preload,  myocardial  contractility  and
postcharge  was  useful  in  guiding  the  ﬂuid  therapy  and  the  use  of  vasoactive  drugs.
Conclusion:  This  case  report  illustrates  the  importance  of  advanced  haemodynamic  monitoring
with an  acceptably  invasive  device  in  obstetric  patients  with  high  cardiac  risk.  The  increasing
experience  in  advanced  haemodynamic  management  will  probably  permit  to  decrease  morbidity
and mortality  of  obstetric  patients  in  the  future.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved. This study was conducted at La Paz University Hospital in Madrid, Spain.
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Análise  do  contorno  do  pulso  calibrado  por  termodiluic¸ão transpulmonar  (Picco  Plus®)
para  o  manejo  perioperatório  de  cesariana  em  paciente  com  miocardiopatia  grave
Resumo
Justiﬁcativa:  O  parto  em  pacientes  cardíacas  é  um  desaﬁo  para  o  anestesiologista,  para  o
qual o  bem-estar  tanto  da  mãe  quanto  do  feto  é  a  questão  principal.  Em  caso  de  cesariana,  o
monitoramento  avanc¸ado  permite  melhorar  a  condic¸ão  hemodinâmica  e  diminuir  a  morbidade
e mortalidade.
Objetivo:  Descrever  o  uso  da  análise  do  contorno  do  pulso  calibrado  por  termodiluic¸ão  transpul-
monar (Picco  Plus®)  para  o  manejo  perioperatório  de  cesariana  em  paciente  com  miocardiopatia
grave.
Relato de  caso: Descrevemos  o  caso  de  uma  paciente  de  28  anos  de  idade  com  uma  doenc¸a
cardíaca  congênita,  submetida  a  uma  cesariana  sob  anestesia  geral  devido  a  afecc¸ão  materna
e apresentac¸ão  fetal  pélvica.  O  manejo  nos  períodos  intraoperatório  e  pós-operatório  foi
otimizado por  monitorac¸ão  hemodinâmica  avanc¸ada  obtida  pela  análise  do  contorno  da  onda
de pulso  e  calibrac¸ão  por  termodiluic¸ão  (monitor  Picco  Plus®).  As  informac¸ões  sobre  pré-carga,
pós-carga  e  contratilidade  miocárdica  foram  úteis  para  orientar  a  reposic¸ão  hídrica  e  o  uso  de
medicamentos  vasoativos.
Conclusão:  Este  relato  de  caso  ilustra  a  importância  da  monitorac¸ão  hemodinâmica  avanc¸ada
com dispositivo  aceitavelmente  invasivo  em  pacientes  obstétricas  com  alto  risco  cardíaco.  O
aumento do  conhecimento  no  manejo  hemodinâmico  avanc¸ado  provavelmente  possibilitará  a
reduc¸ão da  morbidade  e  mortalidade  de  pacientes  obstétricas  no  futuro.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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n  the  last  twenty  years,  the  number  of  patients  with  con-
enital  heart  disease  who  survived  until  the  procreational
ge  has  been  increasing  signiﬁcantly.1 These  patients,
hen  pregnant,  present  a  high  risk  of  cardiovascular
omplications,  and  delivery  by  caesarean  section  (CS)  is  rec-
mmended  for  the  more  severe  cases.2 Moreover,  preventive
nticoagulation  is  common  in  patients  carrying  mechanical
alves,  which  increases  the  risk  of  postpartum  haemorrhage
nd  variations  of  intravascular  volume  during  delivery.3
The  use  of  minimally  invasive  haemodynamic  monitors
as  proven  its  usefulness  in  the  anaesthetic  management
f  cardiac  patients  undergoing  CS4--7 and  cardiac  output
CO)  measurement  with  analysis  of  arterial  pulse  wave
ontour,  calibrated  or  not,  has  been  successfully  employed
n  preeclamptic  patients  undergoing  CS.8
We  describe  the  case  of  a  patient  with  a  severe  left
entricular  dysfunction,  who  was  submitted  to  CS  and  who
eneﬁtted  during  the  perioperative  period  from  a  minimally
nvasive  monitoring,  using  arterial  pulse  contour  wave  anal-
sis  calibrated  with  transpulmonary  thermodilution.
ase report
 28-year-old  patient  was  followed-up  for  her  ﬁrst  preg-
ancy  in  our  tertiary  hospital.  She  had  been  operated
f  an  atrial  septum  defect  (ostium  primum  type)  in  the
hildhood.  In  the  early  post-operative  period  she  had  suf-
ered  a  mitral  endocarditis  that  had  required  a  valve
eplacement,  with  favourable  outcome.  Before  pregnancy,
he  patient  had  no  clinical  signs  of  heart  failure,  except
n
b
t
Syspnoea  type  II  according  to  NYHA  classiﬁcation.  Her  treat-
ent  consisted  of  oral  anticoagulation  (acenocoumarol  --
introm®),  replaced  with  low  molecular  weight  heparin
etween  the  sixth  and  twelfth  week  of  gestation.  The  elec-
rocardiogram  showed  no  signiﬁcant  alterations  and  the
hest  radiograph  revealed  an  increased  cardiothoracic  ratio.
he  transthoracic  echocardiogram  revealed  severe  left  ven-
ricular  systolic  dysfunction  (LVEF  =  24%)  with  no  diastolic
mpact  and  a  tricuspid  regurgitation  with  a  RA-RV  gradient
f  40  mmHg  without  impact  on  right  ventricular  function.
At  34  weeks  of  pregnancy,  she  presented  uterine  con-
ractions,  so  an  emergency  CS  was  indicated  due  to
aternal  pathology  and  breech  presentation.  Oral  anticoag-
lation  was  reversed  by  an  intravenous  dose  of  prothrombin
omplex  (Octaplex®) 40  mL  (1000  IU)  administered  before
ntering  the  operating  room.  After  having  inserted  inter-
al  jugular  vein  and  femoral  arterial  catheters,  a  Picco®
onitor  was  connected  and  calibrated  with  three  consec-
tive  bolus  of  cold  saline.  General  anaesthesia  (GA)  was
nduced  with  a continuous  infusion  of  remifentanil  (Ultiva®)
t  0.15  mcg/kg/min,  etomidate  (Hypnomidato®) 0.3  mg/kg
nd  succinylcholine  (Anectine®) 1  mg/kg,  in  rapid  sequence.
A  was  maintained  with  Sevoﬂurane  (Sevoﬂurane®)  1%.
After  induction  of  GA,  the  patient  presented  hypoten-
ion  and  sinus  rhythm  around  70  bpm.  As  shown  in  Table  1,
he  volumetric  parameters  obtained  from  transpulmonary
hermodilution  (GEDI  and  ITBI)  were  slightly  below  the
cceptable  limit.  CO  was  lower  than  desirable,  especially
ue  to  a  signiﬁcant  decrease  in  systolic  volume  index  (SVI),
ot  compensated  by  tachycardia,  which  could  be  explained
y  the  action  of  remifentanil.  Similarly,  the  cardiac  func-
ion  index  (CFI)  appeared  decreased.  Guided  by  a  value  of
troke  Volume  Variation  (SVV)  above  12--13%,  we  decided  to
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Table  1  Summary  of  perioperative  haemodynamic  values  of  Picco®.
Pre-anaesthetics  values  Post-induction  values  Post-delivery  values  6  h  post-operative  values
BR  (bpm) 70  74  77  68
BP (S/D-M)  (mmHg)  102/48--66  96/42--57  112/53--73  105/55--72
CVP (mmHg)  14  12  15  14
CI (L/min/m2)  2.8  2.7  4.0  3.4
SVV (%)  18  23  19  16
SVI (mL/kg)  40  36  52  50
GEDI (mL/kg)  900  907  1143  733
ITBI (mL/kg)  1080  1134  1273  916
ELWI (mL/kg) 9  8  9  9
CFI (1/min) 3.1  2.9  3.5  4.6
dPmax 900  940  3270  1460
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initiate  a  rapid  infusion  of  250  mL  of  hydroxyethylalmidon
(Voluven®),  conﬁdent  that  the  patient’s  ventricular  function
was  maintained,  and  that  the  ﬂuid  load  would  not  increase
the  extravascular  lung  water  index  (ELWI).  Indeed,  the  result
was  a  signiﬁcant  increase  in  SVI  (well  over  10--15%),  which
normalized  arterial  pressure.  The  ELWI  and  the  CFI  values,
obtained  with  a  new  thermodilution,  conﬁrmed  the  good
response  to  the  loading  volume  and  the  acceptable  efﬁ-
ciency  of  the  ventricle  function.
The  patient  was  delivered  in  7  min,  with  no  signiﬁ-
cant  blood  loss  (200  mL),  and  no  signiﬁcant  haemodynamic
change.  Prophylaxis  of  uterine  atony  was  provided  with  a
slow  infusion  of  10  IU  of  oxytocin  (Syntocinon®),  adminis-
tered  during  30  min.  The  total  amount  of  ﬂuid  infused  along
the  CS  was  750  mL  (500  mL  of  crystalloid  and  250  mL  of  col-
loid)  and  the  surgery  lasted  55  min.
GA  was  reversed  and  the  patient  had  her  trachea  extu-
bated  in  the  operating  room.  She  was  then  transferred  to
the  intensive  care  unit  with  no  haemodynamic  support.  Her
good  clinical  condition  was  conﬁrmed  by  arterial  blood  gas
analysis  (Table  2).
The  anticoagulant  therapy  with  unfractionated  heparin
at  therapeutic  dose  (target  ACT  between  60  and  90  s;  con-
trol  value  of  32  s)  was  started  4  h  after  the  end  of  surgery,
once  conﬁrmed  that  the  patient  did  not  present  excessive
blood  loss  and  that  the  post-operative  blood  tests  were  in
range.
After  48  h,  the  patient  had  maintained  a  stable
haemodynamic  state  with  no  need  for  further  ﬂuid  loads
or  vasoactive  support  (Table  1).  The  jugular  vein  and  the
femoral  arterial  catheters  were  removed  on  the  third  post-
operative  day.  An  echocardiogram  was  performed  on  the
Table  2  Post-operative  data  of  arterial  blood  gas.
Value  Reference  value
pH  7.30  7.35--7.45
pCO2 32.5  35--45  mmHg
pO2 113  83--108  mmHg
HCO3 16  22--26  Meq/L
EB −9  ±3
Lactate  0.9  0.5--2.2  mmol/L
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ourth  day  and  showed  neither  worsening  of  left  ventricular
ystolic  function  (compared  with  preoperative  values)  nor
he  formation  of  intracavitary  thrombus.  Oral  anticoagulant
as  reinitiated  the  same  day,  and  the  patient  was  trans-
erred  to  the  ward  on  the  ﬁfth  day.  On  post-operative  day  10
he  was  discharged  from  the  hospital,  with  no  post-operative
omplication.
iscussion
areful  peripartum  management  of  patients  presenting
ardiac  impairment  can  reduce  both  morbidity  and  mor-
ality.  A  low  myocardial  contractile  reserve,  aggravated  by
hysiological  changes  of  pregnancy,  can  precipitate  acute
eart  failure  during  delivery.  In  the  most  severe  cases,
n  which  expulsive  efforts  might  compromise  the  patient’s
aemodynamic  state,  CS  is  recommended.9 When  vaginal
elivery  is  possible,  a proper  management  of  pain  dur-
ng  labour  avoids  excessive  stimulation  of  the  sympathetic
utonomic  nervous  system,  and  epidural  analgesia  is  a  rec-
mmendable  option  to  provide  efﬁcient  labour  analgesia.3
imilarly,  in  case  of  CS,  neuraxial  anaesthesia  is  a  very
aluable  option:  it  permits  to  avoid  a  tracheal  intubation,
ith  the  risks  of  unpredictable  difﬁcult  airway  and  sympa-
hetic  hyperreﬂexia  during  laryngoscopia.10 In  our  case,  CS
as  performed  under  emergency  conditions  in  an  antico-
gulated  patient  without  predictors  of  difﬁcult  intubation:
hese  were  the  reasons  for  choosing  GA.
The  hypervolemia  associated  with  pregnancy  reaches  its
aximum  in  the  last  weeks  of  gestation,  with  a  nadir  at  the
ime  of  delivery.11 In  non-pregnant  patients  with  left  ven-
ricular  dysfunction,  little  variations  of  pre-  and  afterload
f  the  left  ventricle  are  often  poorly  tolerated,  so  the  risk
f  heart  failure  is  major  at  the  end  of  pregnancy  and  during
elivery.
Haemodynamic  stability  is  essential  to  preserve  the
aternal--foetal  oxygen  transport.  Therefore,  conditions
uch  as  hypotension  need  careful  treatment  to  avoid  ﬂuid
verload  (which  can  precipitate  cardiogenic  pulmonary
edema)  and  unnecessary  administration  of  inotropes
r  vasoconstrictors,  which  can  be  harmful  for  the
oetal--placental  circulation.  When  facing  to  hypotension
uring  CS,  it  is  essential  to  differentiate  hypovolemia  from
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132  
asodilation  and  even  pump  failure.  Low  arterial  pressure
oupled  to  normal  or  increased  CO  should  be  treated  by
areful  infusion  of  vasoconstrictors,  being  the  same  treat-
ent  dangerous  in  hypovolemic  patients,  thus  it  strongly
ecreases  placental  perfusion,  which  lacks  of  autoregula-
ion.  On  the  other  hand,  even  a  hypovolemic  patient  could
adly  respond  to  a  ﬂuid  challenge,  if  the  left  ventricle  is
perating  on  the  ﬂat  part  of  the  Frank--Starling  curve.  In  our
ase,  this  last  scenario  could  be  reasonably  suspected,  thus
 complete  haemodynamic  monitoring,  including  volumetric
arameters,  was  certainly  indicated.
Protocols  based  on  goal  directed  therapy  (GDT)  showed
fﬁciency  to  improve  critical  patient  prognosis.12 In  our  case
e  used  a  typical  strategy  of  GDT,  assuring  primarily  that
ntravascular  volume  was  optimized.  The  left  ventricle’s
bility  to  handle  with  an  increase  in  preload  was  indicated
y  the  SVV,  a  dynamic  parameter  with  good  sensibility  and
peciﬁcity  in  detecting  ﬂuid  responders.13 SVV  can  be  used  in
hythmic,  paralyzed  and  mechanically  ventilated  patients,
hich  was  our  scenario.  Moreover,  we  could  employ  ELWI
o  eventually  detect  cardiac  impairment.  Estimation  of
ung  water  is  obtained  by  transpulmonary  thermodilution
nd,  when  stable,  assure  that  administered  ﬂuids  are  not
ncreasing  cardiac  congestion,  provoking  consequently  pul-
onary  oedema.  Identifying  a  patient  who  responds  to
uid  administration  permits  to  avoid  the  administration  of
asoactive  drugs  (such  as  dobutamine  or  noradrenaline),
hich  have  been  described  to  alter  placental  perfusion  when
ot  indicated.14
Advanced  haemodynamic  monitoring  is  a  must-have  in
bstetric  anaesthesia  when  facing  patients  presenting  with
athologies  like  preeclampsia  or  myocardiopathy,  among
thers.  Pulmonary  arterial  catheterization  represented  the
old  standard  until  few  years  ago  but  its  use  has  been
econsidered  due  to  high  rates  of  complications;  moreover,
ulmonary  arterial  wedge  pressure  has  been  shown  to  poorly
redict  ﬂuid  responsivity.15 Recently,  less  invasive  monitor-
ng  technologies  have  been  developed.  Arterial  pulse  wave
nalysis  allows  reliable  values  of  CO.  Power  analysis  of
rterial  wave,  calibrated  with  lithium  dilution,  has  been
uccessfully  employed  in  preeclamptic  patients8 and  this
echnique  only  requires  peripheral  cannulae  (venous  and
rterial).  Thus,  only  transpulmonary  thermodilution  pro-
ides  an  estimation  of  ELWI  and  we  considered  that  this
arameter  was  essential  in  a  patient  with  left  ventricle  dys-
unction.  Non-invasive  technologies  (volume  clamp  method,
ransthoracic  bioreactance,  suprasternal  Doppler)  represent
 future  hope  to  guide  haemodynamic  treatment  in  risky
atients.16,17
In  conclusion,  the  present  case  illustrates  the  impor-
ance  of  advanced  haemodynamic  monitoring  coupled  to  an
cceptable  level  of  invasivity  in  an  obstetric  patient  with
igh  cardiac  risk.  The  increasing  experience  in  advanced
aemodynamic  management  will  probably  permit  to  further
ecrease  morbidity  and  mortality  of  obstetric  patients  in
he  future.
1N.  Brogly  et  al.
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